Market Snapshot: Sartorius (SRT.DE)
Sartorius (SRT.DE) ticked up 0.48 % during the 24‑hour window ending at 12:16 AM Central Europe on Friday, 23 April. The shares trade at roughly EUR 217 on major exchanges, reflecting a modest increase of 2.44 % since the close of the previous month. With a market capitalisation of EUR 14.3 bn and 69.1 million shares outstanding, the company’s equity value remains substantial, yet its trading volume in the last day—EUR 1.5 mn—is a mere fraction of its market weight, signalling a shallow liquidity base.
Sartorius’ technical profile presents a mixed picture. Its 200‑day simple moving average sits at EUR 186.54, comfortably below the current price, suggesting a bullish trend. Yet the highest price of the past 52 weeks—EUR 215.5—was reached on 10 June 2026, a mere 9.3 % away from today’s level. Conversely, the 52‑week low of EUR 158.2 (3 March 2026) sits 27 % below the current price, illustrating a significant upside potential that remains largely untapped. The gap between the 52‑week high and low indicates a volatile yet potentially lucrative playing field.
Comparative Performance
In the last 24 hours, Sartorius’ peers have shown a spectrum of behaviours:
| Stock | Ticker | 24‑hr % | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| Vonovia | VNA.DE | +0.45 % | EUR 16.59 | EUR 14.2 bn | 3.93 |
| DWS & | DWS.DE | +1.70 % | EUR 63.60 | EUR 13.2 bn | 12.89 |
| Symrise | SY1.DE | +0.25 % | EUR 102.30 | EUR 13.8 bn | 57.15 |
| Hensoldt | HAG.DE | –2.34 % | EUR 83.84 | EUR 10.0 bn | 78.10 |
| Traton | 8TRA.DE | –0.12 % | EUR 33.02 | EUR 16.9 bn | 11.29 |
Sartorius’ performance sits comfortably within the upper echelon of its cohort, outpacing the sector’s most undervalued player (Vonovia) and matching the momentum of DWS &. Yet its price‑to‑earnings ratio remains undefined in the provided data, an omission that obscures a full valuation comparison. The company’s standing—amidst peers with P/E ratios ranging from a bargain‑priced 3.93 to a stretched 78.10—suggests that its valuation could be justified by superior earnings quality or that it remains undervalued relative to the broader industrial bioprocessing sector.
Corporate Profile
Sartorius AG, headquartered in Göttingen, Germany, specialises in precision electronic equipment and components. Its product portfolio spans precision scales for laboratory and industrial use, as well as specialised equipment for biomolecular and microbial separations, cell culture, concentration, fermentation, and purification. Operating on a global scale, the company lists on the Xetra stock exchange and maintains an online presence at www.sartorius.com .
This article synthesises current trading data and technical indicators to present a concise yet critical view of Sartorius’ standing in the market. It highlights the company’s modest recent gains against a backdrop of strong market capitalisation and limited daily liquidity, while positioning it within the performance spectrum of its industrial peers.
